Kobayashi Pharmaceutical Co. Ltd Financials

Market Capitalization ¥395.48 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	36.94
Forward PE	22.53
Price to Sales TTM	¥2.45
Price to Book MRQ	¥1.91
Enterprise to Revenue	2.07
Enterprise to EBITDA	10.88

Financial Reports as of Dec. 31, 2024

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2024-12-31
Profit Margin	6.63%
Operating Margin	7.61%
Return on Assets TTM	5.41%
Return on Equity TTM	5.20%

Income Statement

Revenue TTM	¥161,722,007,552
Revenue per Share TTM	¥2175.49
Quarterly Revenue Growth	-10.60%
Gross Profit TTM	¥83,334,995,968
EBITDA	¥27,041,000,000
Net Income to Common TTM	¥10,714,999,808
Diluted EPS TTM	¥144.02
Quarterly Earnings Growth YoY	66.40%

Balance Sheet

Total Cash MRQ	¥67,278,999,552
Total Cash per Share MRQ	¥905.03
Total Debt MRQ	¥
Total Debt to Equity MRQ	0.38
Current Ratio MRQ	3.34
Book Value per Share MRQ	¥2785.27

Cash Flow

Operating Cash Flow TTM	¥15,992,000,000
Levered Free Cash Flow TTM	¥10,067,000,000

4967 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	74,338,819
Float Shares	29,936,242
Avg 10 Volume	405,340
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	30.83%
% Held by Institutions	21.79%

Stock Price Summary

Beta	0.47
Fifty Two Week Low	¥4850.00
Fifty Two Week High	¥6350.00
Fifty Two Week Change	-2.34%
Day 50 MA	¥5356.48
Day 200 MA	¥5632.44

Dividends and Splits

Forward Annual Dividend Rate	¥88.00
Forward Annual Dividend Yield	1.67%
Trailing Annual Dividend Rate	¥103.00
Trailing Annual Dividend Yield	1.96%
Payout Ratio	70.76%
Dividend Date
Ex Dividend Date	2025-12-29
Last Split Factor
Last Split Date	2016-06-28